Necessity of mediastinal lymph nodes dissection to cure patients with clinical-stage Ⅰ_A non-small cell lung carcinoma
- VernacularTitle:淋巴结廓清程度对cⅠ_A期肺癌预后影响的价值评价
- Author:
Zhou WANG
;
Hongnian YIN
;
Lin ZHANG
- Publication Type:Journal Article
- Keywords:
non small cell lung carcinoma;
clinical stageⅠ A;
mediastinal lymph nodes dissection;
prognosis
- From:
China Oncology
2001;0(02):-
- CountryChina
- Language:Chinese
-
Abstract:
Purpose:To evaluate the efficiency of mediastinal lymph nodes dissection (MLND) and to determine a reasonable extent of dissection in the treatment of patients with clinical stageⅠ A non small cell lung carcinoma (NSCLC). Methods:From January 1988 to June 1995, one hundred and forty seven patients with clinical stageⅠ A NSCLC were treated by surgery. All the patients were divided into three groups according to the type of procedure, that is, resection without MLND, resection with selective MLND and systematic MLND. According to their clinical characteristics patients in each group were matched and assigned once again, and 93 cases were enrolled. Survival rates were calculated by Kaplan meier method and survival curves were prepared and survival difference was compared by Log rank test. Results:Survival rates at 5 year of no MLND, selective MLND and systematic MLND groups were 22.6%, 48.4%, and 51.6%, respectively. Survival rates of two MLND groups were higher than that of no MLND group. Log rank test presented significantly statistical difference between them ( P
